Key facts
- Notable investors include Chengdu Venture Capital Group, Sichuan Development Fund, Chengdu Bio-Town Investment, BioTrack Capital, Sinopharm CICC.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for MICRON Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for MICRON Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MICRON Biotech
Developer and provider of microfluidic technology intended for medical use. The company's technology is applied to three segments of medical aesthetics, drug delivery, and nuclear medicine and enables researchers to realize the adjustable and controllable particle size, structure and function with many application fields, including medical and health, material purification, phase change energy storage and electronic information, providing the healthcare industry with more previse methods of administering and creating novel drugs and therapies.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2022
- Employees
- 60
- Ownership
- Privately Held (backing)
MICRON Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MICRON Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MICRON Biotech in its N-PORT filings yet. We sweep new filings monthly.